MICALL1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.003400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.894000E-01
Normal-vs-Stage2
9.578000E-01
Normal-vs-Stage3
9.233000E-01
Normal-vs-Stage4
4.094800E-01
Stage1-vs-Stage2
4.921000E-01
Stage1-vs-Stage3
6.963800E-01
Stage1-vs-Stage4
7.892600E-01
Stage2-vs-Stage3
9.220400E-01
Stage2-vs-Stage4
6.827000E-01
Stage3-vs-Stage4
8.304600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.122400E-01
Normal-vs-AfricanAmerican
8.028600E-01
Normal-vs-Asian
8.849200E-01
Caucasian-vs-AfricanAmerican
8.672200E-01
Caucasian-vs-Asian
9.684200E-01
AfricanAmerican-vs-Asian
8.952800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.570600E-01
Normal-vs-Female
9.454800E-01
Male-vs-Female
1.669220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.915370E-01
Normal-vs-Age(41-60Yrs)
8.698200E-01
Normal-vs-Age(61-80Yrs)
7.909800E-01
Normal-vs-Age(81-100Yrs)
8.486800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.403200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.286600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.971600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.303170E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.800600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.013200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.512600E-01
Normal-vs-Daily Drinker
8.440600E-01
Normal-vs-Weekly Drinker
5.565000E-01
Normal-vs-Occasional Drinker
6.461600E-01
Normal-vs-Social Drinker
8.534600E-01
Non Drinker-vs-Daily Drinker
9.511400E-01
Non Drinker-vs-Weekly Drinker
2.067200E-01
Non Drinker-vs-Occasional Drinker
1.992210E-01
Non Drinker-vs-Social Drinker
4.994600E-01
Daily Drinker-vs-Weekly Drinker
1.773370E-01
Daily Drinker-vs-Occasional Drinker
1.986450E-01
Daily Drinker-vs-Social Drinker
4.946800E-01
Weekly Drinker-vs-Occasional Drinker
9.891400E-01
Weekly Drinker-vs-Social Drinker
5.461800E-01
Occasional Drinker-vs-Social Drinker
5.730400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.485400E-01
Normal-vs-Grade 2
8.881000E-01
Normal-vs-Grade 3
9.694800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.564500E-03
Grade 1-vs-Grade 3
1.141730E-03
Grade 1-vs-Grade 4
7.485400E-01
Grade 2-vs-Grade 3
7.617600E-02
Grade 2-vs-Grade 4
8.881000E-01
Grade 3-vs-Grade 4
9.694800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.594800E-01
Normal-vs-NonDiabetic
9.503400E-01
Diabetic-vs-NonDiabetic
7.141600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.725000E-01
Normal-vs-NoPancreatitis
9.274200E-01
Pancreatitis-vs-NoPancreatitis
1.397410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.636800E-01
Normal-vs-N1
9.607200E-01
N0-vs-N1
3.785000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.927600E-01
Normal-vs-TP53-NonMutant
4.077600E-01
TP53-Mutant-vs-TP53-NonMutant
1.121030E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
